Vitamin D signaling in myogenesis: Potential for treatment of sarcopenia

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Wagatsuma, Akira ^a   Sakuma, Kunihiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CAVEOLIN 1; COLECALCIFEROL; GLUCOSE TRANSPORTER 4; PHOSPHATIDYLINOSITOL 3 KINASE; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

AGING; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; DNA SYNTHESIS; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; INTRACELLULAR SIGNALING; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE INJURY; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE STRENGTH; MYOBLAST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONCOGENE SRC; PROTEIN SYNTHESIS; REVIEW; SARCOPENIA; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D RESPONSIVE ELEMENT; VITAMIN SUPPLEMENTATION; BLOOD; METABOLISM; PATHOLOGY;

AGING; HUMANS; MUSCLE DEVELOPMENT; RECEPTORS, CALCITRIOL; SARCOPENIA; SIGNAL TRANSDUCTION; VITAMIN D;

EID: 84904695640     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/121254     Document Type: Review

References (141)

1. Rosenberg I. H., Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. The American Journal of Clinical Nutrition 1989 50 5 1231 1233 2-s2.0-0024430754
2. Rosenberg I. H., Sarcopenia: origins and clinical relevance. Journal of Nutrition 1997 127 5, supplement 990S 991S 2-s2.0-0030968884 (Pubitemid 27209486)
3. Cruz-Jentoft A. J., Baeyens J. P., Bauer J. M., Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010 39 4 412 423
4. Goodpaster B. H., Park S. W., Harris T. B., Kritchevsky S. B., Nevitt M., Schwartz A. V., Simonsick E. M., Tylavsky F. A., Visser M., Newman A. B., The loss of skeletal muscle strength, mass, and quality in older adults: The Health, Aging and Body Composition Study. The Journals of Gerontology A; Biological Sciences and Medical Sciences 2006 61 10 1059 1064 2-s2.0-33750927350 (Pubitemid 44727214)
5. Delmonico M. J., Harris T. B., Lee J.-S., Visser M., Nevitt M., Kritchevsky S. B., Tylavsky F. A., Newman A. B., Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. Journal of the American Geriatrics Society 2007 55 5 769 774 2-s2.0-34247568590 10.1111/j.1532-5415.2007.01140.x (Pubitemid 46668965)
6. Aloia J. F., McGowan D. M., Vaswani A. N., Ross P., Cohn S. H., Relationship of menopause to skeletal and muscle mass. The American Journal of Clinical Nutrition 1991 53 6 1378 1383 2-s2.0-0025864873 (Pubitemid 21898887)
7. Hughes V. A., Frontera W. R., Roubenoff R., Evans W. J., Fiatarone Singh M. A., Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. The American Journal of Clinical Nutrition 2002 76 2 473 481 2-s2.0-0036073319 (Pubitemid 34804075)
8. Nair K. S., Aging muscle. The American Journal of Clinical Nutrition 2005 81 5 953 963 2-s2.0-20544440861 (Pubitemid 41724933)
9. Mitchell W. K., Williams J., Atherton P., Larvin M., Lund J., Narici M., Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Frontiers in Physiology 2012 3, article 260 2-s2.0-84866502856 10.3389/fphys.2012.00260
10. Augustin H., Partridge L., Invertebrate models of age-related muscle degeneration. Biochimica et Biophysica Acta-General Subjects 2009 1790 10 1084 1094 2-s2.0-69949109492 10.1016/j.bbagen.2009.06.011
11. Demontis F., Piccirillo R., Goldberg A. L., Perrimon N., Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models. Disease Models & Mechanisms 2013 6 6 1339 1352
12. Baumgartner R. N., Koehler K. M., Gallagher D., Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology 1998 147 8 755 763 2-s2.0-0033564767 (Pubitemid 28183275)
13. Janssen I., Heymsfield S. B., Ross R., Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society 2002 50 5 889 896 2-s2.0-0036246979 10.1046/j.1532-5415.2002.50216.x (Pubitemid 34496687)
14. Lauretani F., Russo C. R., Bandinelli S., Bartali B., Cavazzini C., Di Iorio A., Corsi A. M., Rantanen T., Guralnik J. M., Ferrucci L., Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. Journal of Applied Physiology 2003 95 5 1851 1860 2-s2.0-10744233728 (Pubitemid 37310367)
15. Rolland Y., Lauwers-Cances V., Cournot M., Nourhashémi F., Reynish W., Rivière D., Vellas B., Grandjean H., Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. Journal of the American Geriatrics Society 2003 51 8 1120 1124 2-s2.0-0041521039 10.1046/j.1532-5415.2003.51362.x (Pubitemid 36993470)
16. Janssen I., Influence of sarcopenia on the development of physical disability: the cardiovascular health study. Journal of the American Geriatrics Society 2006 54 1 56 62 2-s2.0-33645141176 10.1111/j.1532-5415.2005.00540.x
17. von Haehling S., Morley J. E., Anker S. D., An overview of sarcopenia: facts and numbers on prevalence and clinical impact. Journal of Cachexia, Sarcopenia and Muscle 2010 1 2 129 133 2-s2.0-79955612531 10.1007/s13539-010- 0014-2
18. Janssen I., Shepard D. S., Katzmarzyk P. T., Roubenoff R., The healthcare costs of sarcopenia in the United States. Journal of the American Geriatrics Society 2004 52 1 80 85 2-s2.0-0346499181 10.1111/j.1532-5415.2004.52014.x (Pubitemid 38090394)
19. What Works: Healing the Healthcare Staffing Shortage. Pricewaterhouse-Coopers Health Research Institute, 2007
20. World Population Ageing 1950-2050, Department of Economic and Social Affairs, United Nations, 2001, http://www.un.org/esa/population/publications/ worldageing19502050/
21. 3 receptor in human skeletal muscle tissue. The Histochemical Journal 2001 33 1 19 24 2-s2.0-0035061672 10.1023/A:1017535728844 (Pubitemid 32368054)
22. Bischoff-Ferrari H. A., Borchers M., Gudat F., Dürmüller U., Dick W., Vitamin D receptor expression in human muscle tissue decreases with age. Journal of Bone and Mineral Research 2004 19 2 265 269 2-s2.0-1642485799 10.1359/jbmr.2004.19.2.265 (Pubitemid 38116740)
23. Ceglia L., da Silva Morais M., Park L. K., Morris E., Harris S. S., Bischoff-Ferrari H. A., Fielding R. A., Dawson-Hughes B., Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. Journal of Molecular Histology 2010 41 2-3 137 142 2-s2.0-77955918415 10.1007/s10735-010-9270-x
24. Wang Y., DeLuca H. F., Is the vitamin D receptor found in muscle? Endocrinology 2011 152 2 354 363 2-s2.0-79951646427 10.1210/en.2010-1109
25. Wang Y., Zhu J., DeLuca H. F., Where is the vitamin D receptor? Archives of Biochemistry and Biophysics 2012 523 1 123 133 2-s2.0-84861577440 10.1016/j.abb.2012.04.001
26. 12 skeletal muscle cells. Endocrinology 2011 152 8 2976 2986 2-s2.0-79960711583 10.1210/en.2011-0159
27. 12 myoblasts. Cell Biology International 2012 36 5 441 447 2-s2.0-84862505959 10.1042/CBI20100782
28. 12 skeletal muscle cells. Journal of Cellular Biochemistry 2012 113 4 1170 1181 2-s2.0-84857550868 10.1002/jcb.23444
29. 12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. American Journal of Physiology-Cell Physiology 2012 303 4 C396 C405 2-s2.0-84865131204 10.1152/ajpcell.00014.2012
30. Ryan K. J., Daniel Z. C., Craggs L. J., Parr T., Brameld J. M., Dose-dependent effects of vitamin D on transdifferentiation of skeletal muscle cells to adipose cells. Journal of Endocrinology 2013 217 1 45 58 2-s2.0-84877107028 10.1530/JOE-12-0234
31. Tanaka M., Kishimoto K. N., Okuno H., Saito H., Itoi E., Vitamin D receptor gene silencing effects on differentiation of myogenic cell lines. Muscle & Nerve 2014 49 5 700 708
32. 12 skeletal muscle cells. Endocrinology 2014 155 2 347 357
33. Jones G., Strugnell S. A., DeLuca H. F., Current understanding of the molecular actions of vitamin D. Physiological Reviews 1998 78 4 1193 1231 2-s2.0-0031755168 (Pubitemid 28491953)
34. Lösel R., Wehling M., Nongenomic actions of steroid hormones. Nature Reviews Molecular Cell Biology 2003 4 1 46 56 2-s2.0-0037224484 10.1038/nrm1009 (Pubitemid 36077256)
35. Deeb K. K., Trump D. L., Johnson C. S., Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nature Reviews Cancer 2007 7 9 684 700 2-s2.0-34548202165 10.1038/nrc2196 (Pubitemid 47327412)
36. Girgis C. M., Clifton-Bligh R. J., Hamrick M. W., Holick M. F., Gunton J. E., The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocrine Reviews 2013 34 1 33 83 2-s2.0-84874368830 10.1210/er.2012-1012
37. Bouillon R., Okamura W. H., Norman A. W., Structure-function relationships in the vitamin D endocrine system. Endocrine Reviews 1995 16 2 200 257 2-s2.0-0028988403
38. 3 metabolism in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 2004 92 4 317 325 2-s2.0-12344301273 10.1016/j.jsbmb.2004.10.007 (Pubitemid 40128252)
39. 3: genomic and non-genomic mechanisms. Best Practice & Research: Clinical Endocrinology and Metabolism 2011 25 4 543 559 2-s2.0-80052197647 10.1016/j.beem.2011.05.010
40. 3 target genes. Molecular Endocrinology 2005 19 11 2685 2695 2-s2.0-27644595302 10.1210/me.2005-0106 (Pubitemid 41577243)
41. 3 metabolites on calcium fluxes in intact chicken skeletal muscle and myoblasts cultured in vitro. Calcified Tissue International 1984 36 2 200 205 2-s2.0-0021285079 (Pubitemid 14026354)
42. 3 receptors and activities in muscle. The Journal of Biological Chemistry 1985 260 15 8882 8891 2-s2.0-0022256118 (Pubitemid 15011982)
43. Drittanti L., de Boland A. R., Boland R., Modulation of DNA synthesis in cultured muscle cells by 1,25-dihydroxyvitamin D-3. Biochimica et Biophysica Acta-Molecular Cell Research 1989 1014 2 112 119 2-s2.0-0024465164 (Pubitemid 19283086)
44. 3 regulation of chick myoblast proliferation and differentiation. Molecular and Cellular Endocrinology 1999 153 1-2 39 45 2-s2.0-0345517254 10.1016/S0303-7207(99)00093-3 (Pubitemid 29339155)
45. 12 skeletal muscle cells. IUBMB Life 2002 53 3 175 181 2-s2.0-0036280792 10.1080/15216540212334 (Pubitemid 34686059)
46. Endo I., Inoue D., Mitsui T., Umaki Y., Akaike M., Yoshizawa T., Kato S., Matsumoto T., Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003 144 12 5138 5144 2-s2.0-0344943235 10.1210/en.2003-0502 (Pubitemid 37476038)
47. Kitamura T., Kitamura Y. I., Funahashi Y., Shawber C. J., Castrillon D. H., Kollipara R., DePinho R. A., Kitajewski J., Accili D., A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. The Journal of Clinical Investigation 2007 117 9 2477 2485 2-s2.0-34848838902 10.1172/JCI32054 (Pubitemid 47494349)
48. Buas M. F., Kadesch T., Regulation of skeletal myogenesis by Notch. Experimental Cell Research 2010 316 18 3028 3033 2-s2.0-77957686086 10.1016/j.yexcr.2010.05.002
49. Ezura Y., Tournay O., Nifuji A., Noda M., Identification of a novel suppressive vitamin D response sequence in the 5′-Flanking region of the murine Id1 gene. The Journal of Biological Chemistry 1997 272 47 29865 29872 2-s2.0-0030701537 10.1074/jbc.272.47.29865 (Pubitemid 27508085)
50. 3 in rat osteoblastic osteosarcoma cells. Proceedings of the National Academy of Sciences of the United States of America 1992 89 10 4569 4572 2-s2.0-0026550135
51. Lasorella A., Benezra R., Iavarone A., The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nature Reviews. Cancer 2014 14 2 77 91
52. Jen Y., Weintraub H., Benezra R., Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes & Development 1992 6 8 1466 1479 2-s2.0-0026765031
53. 3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells. Journal of Cellular Biochemistry 2002 86 1 128 135 2-s2.0-0035986599 10.1002/jcb.10191 (Pubitemid 34595019)
54. Shaul P. W., Anderson R. G., Role of plasmalemmal caveolae in signal transduction. American Journal of Physiology-Lung Cellular and Molecular Physiology 1998 275 5 L843 L851 2-s2.0-0031765341
55. 3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells. The Journal of Steroid Biochemistry and Molecular Biology 2010 121 1-2 169 175 2-s2.0-77954762255 10.1016/j.jsbmb.2010.03.002
56. 3-MARRS) and phosphate uptake in intestinal cells. Proceedings of the National Academy of Sciences of the United States of America 2004 101 19 7392 7397 2-s2.0-2442624604 10.1073/pnas.0402207101 (Pubitemid 38638043)
57. 3-MARRS receptor: multiple functional roles in diverse cell systems. Current Medicinal Chemistry 2007 14 10 1087 1093 2-s2.0-34247555889 10.2174/092986707780362871 (Pubitemid 46672627)
58. 3 signalling to the nucleus in muscle cells. Biochimica et Biophysica Acta-Molecular Cell Research 2001 1541 3 179 187 2-s2.0-0035915482 10.1016/S0167-4889(01)00142-2 (Pubitemid 34045125)
59. 12 muscle cell line. Journal of Cellular Biochemistry 2006 97 4 698 708 2-s2.0-33645000995 10.1002/jcb.20639
60. 3 regulation of the mitogen-activated protein kinase pathway in muscle cells. The Journal of Biological Chemistry 2003 278 4 2199 2205 2-s2.0-0037715153 10.1074/jbc. M205732200 (Pubitemid 36801286)
61. Tateno M., Nishida Y., Adachi-Yamada T., Regulation of JNK by Src during Drosophila development. Science 2000 287 5451 324 327 2-s2.0-0033979243 10.1126/science.287.5451.324 (Pubitemid 30046764)
62. Jones N. C., Fedorov Y. V., Rosenthal R. S., Olwin B. B., ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. Journal of Cellular Physiology 2001 186 1 104 115
63. 12 myogenesis. The Journal of Biological Chemistry 1999 274 7 4341 4346 2-s2.0-0033548233 10.1074/jbc.274.7.4341 (Pubitemid 29090970)
64. Zetser A., Gredinger E., Bengal E., p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation: participation of the MEF2C transcription factor. The Journal of Biological Chemistry 1999 274 8 5193 5200 2-s2.0-0033582459 10.1074/jbc.274.8.5193 (Pubitemid 29113429)
65. Wu Z., Woodring P. J., Bhakta K. S., Tamura K., Wen F., Feramisco J. R., Karin M., Wang J. Y. J., Puri P. L., p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Molecular and Cellular Biology 2000 20 11 3951 3964 2-s2.0-0034067079 10.1128/MCB.20.11.3951-3964.2000 (Pubitemid 30314494)
66. 12 cells. Cellular Signalling 2007 19 11 2286 2295 2-s2.0-34548431604 10.1016/j.cellsig.2007.07.002 (Pubitemid 47361684)
67. McPherron A. C., Lawler A. M., Lee S.-J., Regulation of skeletal muscle mass in mice by a new TGF- β superfamily member. Nature 1997 387 6628 83 90 2-s2.0-0031010050 (Pubitemid 27202654)
68. Wilson E. M., Rotwein P., Selective control of skeletal muscle differentiation by Akt1. The Journal of Biological Chemistry 2007 282 8 5106 5110 2-s2.0-34247171304 10.1074/jbc.C600315200 (Pubitemid 47093711)
69. van der Wielen R. P., Lowik M. R., van dan Berg H., de Groot L. C., Haller J., Moreiras O., van Staveren W. A., Serum vitamin D concentrations among elderly people in Europe. The Lancet 1995 346 8969 207 210 2-s2.0-0029017882
70. Holick M. F., Vitamin D deficiency. The New England Journal of Medicine 2007 357 3 266 281 2-s2.0-34447514029 10.1056/NEJMra070553 (Pubitemid 47080391)
71. 3 The Journal of Clinical Investigation 1985 76 4 1536 1538 2-s2.0-0022351148 (Pubitemid 16193572)
72. Yoshikawa S., Nakamura T., Tanabe H., Imamura T., Osteomalacic myopathy. Endocrinologia Japonica 1979 26, supplement 65 72 2-s2.0-0018485750
73. Scelsi R., Marchetti C., Poggi P., Histochemical and ultrastructural aspects of M. vastus lateralis in sedentary old people (age 65-89 years). Acta Neuropathologica 1980 51 2 99 105 2-s2.0-0018958337 (Pubitemid 10039116)
74. Andersen J. L., Muscle fibre type adaptation in the elderly human muscle. Scandinavian Journal of Medicine & Science in Sports 2003 13 1 40 47 2-s2.0-0038137389 10.1034/j.1600-0838.2003.00299.x (Pubitemid 37463578)
75. Chargé S. B. P., Rudnicki M. A., Cellular and molecular regulation of muscle regeneration. Physiological Reviews 2004 84 1 209 238 2-s2.0-0347989458 10.1152/physrev.00019.2003 (Pubitemid 38049880)
76. Verdijk L. B., Koopman R., Schaart G., Meijer K., Savelberg H. H. C. M., Van Loon L. J. C., Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. American Journal of Physiology- Endocrinology and Metabolism 2007 292 1 E151 E157 2-s2.0-33845999544 10.1152/ajpendo.00278.2006 (Pubitemid 46052937)
77. Scott W., Stevens J., Binder-Macleod S. A., Human skeletal muscle fiber type classifications. Physical Therapy 2001 81 11 1810 1816 2-s2.0-0034764260 (Pubitemid 33027477)
78. 3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells. The Journal of Steroid Biochemistry and Molecular Biology 2013 136 1 125 130 2-s2.0-84881130275 10.1016/j.jsbmb.2013.02.013
79. Brack A. S., Rando T. A., Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Reviews 2007 3 3 226 237 2-s2.0-36248973631 10.1007/s12015-007-9000-2 (Pubitemid 350129709)
80. Carosio S., Berardinelli M. G., Aucello M., Musarò A., Impact of ageing on muscle cell regeneration. Ageing Research Reviews 2011 10 1 35 42 2-s2.0-78650239733 10.1016/j.arr.2009.08.001
81. Jang Y. C., Sinha M., Cerletti M., Dall'osso C., Wagers A. J., Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. Cold Spring Harbor Symposia on Quantitative Biology 2011 76 101 111 2-s2.0-84867410773 10.1101/sqb.2011.76.010652
82. Relaix F., Zammit P. S., Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 2012 139 16 2845 2856 2-s2.0-84864317860 10.1242/dev.069088
83. Mauro A., Adams W. R., The structure of the sarcolemma of the frog skeletal muscle fiber. The Journal of Biophysical and Biochemical Cytology 1961 10 4, supplement 177 185 2-s2.0-44449140897
84. Hawke T. J., Garry D. J., Myogenic satellite cells: physiology to molecular biology. Journal of Applied Physiology 2001 91 2 534 551 2-s2.0-0034918907 (Pubitemid 32681081)
85. Stratos I., Li Z., Herlyn P., Rotter R., Behrendt A.-K., Mittlmeier T., Vollmar B., Vitamin D increases cellular turnover and functionally restores the skeletal muscle after crush injury in rats. American Journal of Pathology 2013 182 3 895 904 2-s2.0-84874547126 10.1016/j.ajpath.2012.11.006
86. Zimmet P., Alberti K. G., Shaw J., Global and societal implications of the diabetes epidemic. Nature 2001 414 6865 782 787 2-s2.0-0035856920 10.1038/414782a (Pubitemid 34000780)
87. Park S. W., Goodpaster B. H., Lee J. S., Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 2009 32 11 1993 1997 2-s2.0-70449358688 10.2337/dc09-0264
88. Mitri J., Muraru M. D., Pittas A. G., Vitamin D and type 2 diabetes: a systematic review. European Journal of Clinical Nutrition 2011 65 9 1005 1015 2-s2.0-80052600114 10.1038/ejcn.2011.118
89. Jessen N., Goodyear L. J., Contraction signaling to glucose transport in skeletal muscle. Journal of Applied Physiology 2005 99 1 330 337 2-s2.0-21644436729 10.1152/japplphysiol.00175.2005 (Pubitemid 40934499)
90. 2S formation in 3T3L1 adipocytes. The Journal of Biological Chemistry 2012 287 50 42324 42332 2-s2.0-84871282327 10.1074/jbc.M112.407833
91. Kabil O., Banerjee R., Redox biochemistry of hydrogen sulfide. The Journal of Biological Chemistry 2010 285 29 21903 21907 2-s2.0-77954579286 10.1074/jbc.R110.128363
92. Tamilselvan B., Seshadri K. G., Venkatraman G., Role of vitamin D on the expression of glucose transporters in L6 myotubes. Indian Journal of Endocrinology and Metabolism 2013 17 supplement 1 S326 S328
93. 3 share intracellular signal transduction in glucose homeostasis in soleus muscle. The International Journal of Biochemistry & Cell Biology 2014 48 18 27
94. Lund S., Holman G. D., Schmitz O., Pedersen O., Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proceedings of the National Academy of Sciences of the United States of America 1995 92 13 5817 5821 2-s2.0-0029064123 10.1073/pnas.92.13.5817
95. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979 206 4423 1188 1190 2-s2.0-0018578621 (Pubitemid 10159658)
96. Colston K., Hirst M., Feldman D., Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology 1980 107 6 1916 1922 2-s2.0-0019169417 (Pubitemid 11194706)
97. 3 receptor in the male rat. Biochemical and Biophysical Research Communications 1991 181 2 611 616
98. Zanello S. B., Collins E. D., Marinissen M. J., Norman A. W., Boland R. L., Vitamin d receptor expression in chicken muscle tissue and cultured myoblasts. Hormone and Metabolic Research 1997 29 5 231 236 2-s2.0-0030854043 (Pubitemid 27287901)
99. 3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 1986 119 5 2214 2220 2-s2.0-0022972788 (Pubitemid 17171405)
100. 3 receptor in chick skeletal muscle myoblasts. Biochemical and Biophysical Research Communications 1985 128 1 305 311 2-s2.0-0022401639 (Pubitemid 16234077)
101. 3 correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR-Src interaction. Journal of Cellular Biochemistry 2000 79 2 274 281
102. 3 Biochemical and Biophysical Research Communications 2001 289 5 1150 1156 2-s2.0-0035930974 10.1006/bbrc.2001.6072 (Pubitemid 34076311)
103. 3 by VDR-dependent and -independent mechanisms in muscle cells. Steroids 2002 67 6 477 482 2-s2.0-0036226485 10.1016/S0039-128X(01)00182-9 (Pubitemid 34311763)
104. 12 skeletal myotubes. Molecular Nutrition & Food Research 2013 57 12 2137 2146
105. Wang Y., Becklund B. R., DeLuca H. F., Identification of a highly specific and versatile vitamin D receptor antibody. Archives of Biochemistry and Biophysics 2010 494 2 166 177 2-s2.0-75549087005 10.1016/j.abb.2009.11.029
106. 12 myoblast differentiation. Molecular and Cellular Proteomics 2005 4 7 887 901 2-s2.0-24944559026 10.1074/mcp.M400182-MCP200 (Pubitemid 41309147)
107. Zehnder D., Bland R., Williams M. C., Mcninch R. W., Howie A. J., Stewart P. M., Hewison M., Extrarenal expression of 25-hydroxyvitamin D3-1 α -hydroxylase. Journal of Clinical Endocrinology & Metabolism 2001 86 2 888 894 2-s2.0-0035092887 10.1210/jc.86.2.888 (Pubitemid 32207511)
108. Adams J. S., Hewison M., Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Archives of Biochemistry and Biophysics 2012 523 1 95 102 2-s2.0-84861575206 10.1016/j.abb.2012.02.016
109. 3 1 α-hydroxylase from rat kidney mitochondria. FEBS Letters 1997 419 1 45 48 2-s2.0-0031463756 10.1016/S0014-5793(97)01432-4 (Pubitemid 28011214)
110. 3 is an agonistic vitamin D receptor ligand. The Journal of Steroid Biochemistry and Molecular Biology 2010 118 3 162 170
111. Bismuth K., Relaix F., Genetic regulation of skeletal muscle development. Experimental Cell Research 2010 316 18 3081 3086 2-s2.0-77957679990 10.1016/j.yexcr.2010.08.018
112. Braun T., Rudnicki M. A., Arnold H.-H., Jaenisch R., Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 1992 71 3 369 382 2-s2.0-0026437438 10.1016/0092-8674(92)90507-9
113. Rudnicki M. A., Braun T., Hinuma S., Jaenisch R., Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 1992 71 3 383 390 2-s2.0-0026440992 10.1016/0092-8674(92)90508-A
114. Hasty P., Bradley A., Morris J. H., Edmondson D. G., Venuti J. M., Olson E. N., Klein W. H., Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 1993 364 6437 501 506 2-s2.0-0027258162 10.1038/364501a0 (Pubitemid 23273093)
115. Nabeshima Y., Hanaoka K., Hayasaka M., Esumi E., Li S., Nonaka I., Nabeshima-Y. I., Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 1993 364 6437 532 535 2-s2.0-0027297310 10.1038/364532a0 (Pubitemid 23273098)
116. Rawls A., Valdez M. R., Zhang W., Richardson J., Klein W. H., Olson E. N., Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice. Development 1998 125 13 2349 2358 2-s2.0-0031927208 (Pubitemid 28362395)
117. Lassar A. B., Davis R. L., Wright W. E., Kadesch T., Murre C., Voronova A., Baltimore D., Weintraub H., Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 1991 66 2 305 315 2-s2.0-0025808242 10.1016/0092-8674(91)90620-E (Pubitemid 121001368)
118. Sun X.-H., Baltimore D., An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell 1991 64 2 459 470 2-s2.0-0026020867 (Pubitemid 121001269)
119. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Shoichi M., Akiyoshi F., Toshio M., Kato S., Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Genetics 1997 16 4 391 396 2-s2.0-0030763857 10.1038/ng0897-391 (Pubitemid 27323308)
120. Sakoda K., Fujiwara M., Arai S., Suzuki A., Nishikawa J.-I., Imagawa M., Nishihara T., Isolation of a genomic DNA fragment having negative vitamin D response element. Biochemical and Biophysical Research Communications 1996 219 1 31 35 2-s2.0-0030049971 10.1006/bbrc.1996.0176 (Pubitemid 26071599)
121. Nishishita T., Okazaki T., Ishikawa T., Igarashi T., Hata K., Ogata E., Fujita T., A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D. The Journal of Biological Chemistry 1998 273 18 10901 10907 2-s2.0-0032079521 10.1074/jbc.273.18.10901 (Pubitemid 28204927)
122. Seoane S., Alonso M., Segura C., Pérez-Fernández R., Localization of a negative vitamin D response sequence in the human growth hormone gene. Biochemical and Biophysical Research Communications 2002 292 1 250 255 2-s2.0-0036290224 10.1006/bbrc.2002.6641 (Pubitemid 34687356)
123. Dotto G. P., p21(WAF1/Cip1): more than a break to the cell cycle? Biochimica et Biophysica Acta-Reviews on Cancer 2000 1471 1 M43 M56 2-s2.0-0034738420 10.1016/S0304-419X(00)00019-6
124. Sherr C. J., Roberts J. M., CDK inhibitors: positive and negative regulators of G1-phase progression. Genes & Development 1999 13 12 1501 1512 2-s2.0-0033564697 (Pubitemid 29297917)
125. Nevins J. R., E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992 258 5081 424 429 2-s2.0-0026526437
126. Sherr C. J., Cancer cell cycles. Science 1996 274 5293 1672 1677 2-s2.0-0029849620 10.1126/science.274.5293.1672 (Pubitemid 26414890)
127. Amthor H., Nicholas G., McKinnell I., Kemp C. F., Sharma M., Kambadur R., Patel K., Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Developmental Biology 2004 270 1 19 30 2-s2.0-2342515391 10.1016/j.ydbio.2004.01.046 (Pubitemid 38596926)
128. Kocamis H., Gahr S. A., Batelli L., Hubbs A. F., Killefer J., IGF-I, IGF-II, and IGF-receptor-1 transcript and IGF-II protein expression in myostatin knockout mice tissues. Muscle & Nerve 2002 26 1 55 63 2-s2.0-0036301718 10.1002/mus.10160 (Pubitemid 34734396)
129. Gilson H., Schakman O., Combaret L., Lause P., Grobet L., Attaix D., Ketelslegers J. M., Thissen J.-P., Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 2007 148 1 452 460 2-s2.0-33845905819 10.1210/en.2006-0539 (Pubitemid 46021477)
130. Marshall A., Salerno M. S., Thomas M., Davies T., Berry C., Dyer K., Bracegirdle J., Watson T., Dziadek M., Kambadur R., Bower R., Sharma M., Mighty is a novel promyogenic factor in skeletal myogenesis. Experimental Cell Research 2008 314 5 1013 1029 2-s2.0-39549086113 10.1016/j.yexcr.2008.01.004
131. Gilson H., Schakman O., Kalista S., Lause P., Tsuchida K., Thissen J.-P., Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. American Journal of Physiology-Endocrinology and Metabolism 2009 297 1 E157 E164 2-s2.0-67650071006 10.1152/ajpendo.00193.2009
132. Miyake M., Hayashi S., Taketa Y., Iwasaki S., Watanabe K., Ohwada S., Aso H., Yamaguchi T., Myostatin down-regulates the IGF-2 expression via ALK-Smad signaling during myogenesis in cattle. Animal Science Journal 2010 81 2 223 229 2-s2.0-77953080864 10.1111/j.1740-0929.2009.00725.x
133. Williams N. G., Interlichia J. P., Jackson M. F., Hwang D., Cohen P., Rodgers B. D., Endocrine actions of myostatin: systemic regulation of the igf and igf binding protein axis. Endocrinology 2011 152 1 172 180 2-s2.0-78650843513 10.1210/en.2010-0488
134. Duan C., Ren H., Gao S., Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. General and Comparative Endocrinology 2010 167 3 344 351 2-s2.0-77953356748 10.1016/j.ygcen.2010.04.009
135. Zanou N., Gailly P., Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways. Cellular and Molecular Life Sciences 2013 70 21 4117 4130 2-s2.0-84875489909 10.1007/s00018-013-1330-4
136. Shen X., Collier J. M., Hlaing M., Zhang L., Delshad E. H., Bristow J., Bernstein H. S., Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Developmental Dynamics 2003 226 1 128 138 2-s2.0-12244273711 10.1002/dvdy.10200 (Pubitemid 36043470)
137. Amirouche A., Durieux A.-C., Banzet S., Koulmann N., Bonnefoy R., Mouret C., Bigard X., Peinnequin A., Freyssenet D., Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology 2009 150 1 286 294 2-s2.0-58149471229 10.1210/en.2008-0959
138. Sartori R., Milan G., Patron M., Mammucari C., Blaauw B., Abraham R., Sandri M., Smad2 and 3 transcription factors control muscle mass in adulthood. American Journal of Physiology-Cell Physiology 2009 296 6 C1248 C1257 2-s2.0-66749167618 10.1152/ajpcell.00104.2009
139. Trendelenburg A. U., Meyer A., Rohner D., Boyle J., Hatakeyama S., Glass D. J., Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. American Journal of Physiology-Cell Physiology 2009 296 6 C1258 C1270 2-s2.0-66749188280 10.1152/ajpcell.00105.2009
140. Lipina C., Kendall H., McPherron A. C., Taylor P. M., Hundal H. S., Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice. FEBS Letters 2010 584 11 2403 2408 2-s2.0-77952957076 10.1016/j.febslet.2010.04.039
141. Sarbassov D. D., Ali S. M., Sabatini D. M., Growing roles for the mTOR pathway. Current Opinion in Cell Biology 2005 17 6 596 603 2-s2.0-27544500981 10.1016/j.ceb.2005.09.009 (Pubitemid 41540408)